Emergent BioSolutions (EBS) Inventory (2010 - 2026)

Emergent BioSolutions' Inventory history runs 17 years deep, the most recent figure standing at $327.6 million for Q1 2026.

• In Q1 2026, Inventory rose 4.33% year-over-year to $327.6 million; the TTM figure through Mar 2026 stood at $327.6 million (up 4.33% YoY), while the FY2025 annual figure was $343.4 million, up 10.17% from the prior year.
• Inventory was $327.6 million for Q1 2026 at Emergent BioSolutions, down from $343.4 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $528.2 million in Q3 2022 to a low of $311.7 million in Q4 2024.
• Historically, Inventory has averaged $357.4 million across 5 years, with a median of $343.4 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Inventory surged 44.87% in 2022, then sank 32.96% in 2023.
• A 5-year view of Inventory shows it stood at $350.7 million in 2022, then dropped by 6.22% to $328.9 million in 2023, then decreased by 5.23% to $311.7 million in 2024, then advanced by 10.17% to $343.4 million in 2025, then decreased by 4.6% to $327.6 million in 2026.
• The last three Inventory figures came in at $327.6 million (Q1 2026), $343.4 million (Q4 2025), and $356.3 million (Q3 2025), per Business Quant data.